AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
#75 – Breakpoints Talks Breakpoints: Aminoglycosides
Breakpoints
Pseudomonas and Aminoglycosides: A Comparison
Pip Tengza: I think what happened with pseudo maybe arguably is even more controversial. The changes with Pseudomonas are more drastic and really clinicians need to know what's up with this, he says. "The take home from the M100 for 2023 from CLS side that will most blow people's minds," Pang added.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode